Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
Cohort Analysis
76%
Diabetes Mellitus
45%
Inpatient
43%
Glucose
43%
Fragility Fracture
38%
Combination Therapy
38%
Bone
38%
Systematic Review
38%
Fracture
34%
Therapeutic Procedure
28%
Association
25%
Health
23%
Spine Fracture
22%
Cardiovascular Disease
22%
Glucagon-Like Peptide-1 Agonist
21%
Hypoglycemia
21%
Sodium Glucose Cotransporter 2 Inhibitor
19%
Exercise
19%
Patient with Diabetes
19%
Glucose Metabolism
19%
Chemotherapeutic Agent
19%
Drug
19%
Impaired Glucose Tolerance
19%
All Cause Mortality
19%
Patient
17%
Diabetes
13%
Incidence
11%
Woman
11%
Bone Turnover
10%
Age
9%
Bone Mass
9%
Glycon
8%
Hazard Ratio
7%
Hemoglobin A1c
7%
Analysis
7%
Marker
6%
Osteoblast
6%
Differentiation
6%
Muscle
6%
Forearm Fracture
5%
Drug Prescription
5%
Adult
5%
Insulin
5%
Patient Registry
5%
Pharmacology, Toxicology and Pharmaceutical Science
Fracture
81%
Cohort Study
78%
Fragility Fracture
72%
Sodium Glucose Cotransporter 2 Inhibitor
57%
Non Insulin Dependent Diabetes Mellitus
53%
Glucagon Like Peptide 1 Receptor Agonist
41%
Dipeptidyl Peptidase IV Inhibitor
41%
Alendronic Acid
38%
Metformin
31%
Diabetes Mellitus
24%
Glucose
21%
Denosumab
19%
Case-Control Study
19%
Drug
19%
Sulfonylurea
10%
ICD-10
10%
Prescription Drug
10%
Patient Registry
7%
Dose-Response Relationship
5%
Nursing and Health Professions
Non Insulin Dependent Diabetes Mellitus
40%
Alendronic Acid
38%
Fracture
28%
Diabetes Mellitus
24%
Glucose
21%
Fragility Fracture
19%
Denosumab
19%
Drug
19%
Systematic Review
19%
Cohort Analysis
19%
Patient with Diabetes
19%
Elderly Patient
19%
Prescription
15%
Diagnosis
15%
Dose
8%
Patient with Type 2 Diabetes
8%
Woman
7%
Patient
7%
Weight
6%
Control
5%
Man
5%
Discharge
5%
Classification
5%
Health Service
5%
ICD-10
5%
